San Diego, CA, USA/Glasgow, Scotland – 25 June 2014 - Scotland-based BioOutsource will be opening a new lab facility in Massachusetts in 2015. The company, a global leader in biologics contract testing and BioSimilar characterization for the biopharmaceutical industry, opened their first U.S. office in 2013 in the life sciences hub of Cambridge, MA. The company plans to open the new laboratory facility in early 2015 to service their North American & Latin American clients. The new Laboratory Facility will support and strengthen the company’s BioSimilar and BioSafety service offerings.
“We welcome BioOutsource’s expansion in Massachusetts and look forward to their ongoing contributions to our thriving life sciences community,” said Massachusetts Governor Deval Patrick.
“North America has always been an essential strategic element of our global expansion plans, exemplified by our US office and active membership of MassBio,” said BioOutsource CEO, Gerry McKay. “We are already a Global company and the time is right to extend our global client footprint with the addition of a new facility in the US. The new facility will benefit our existing and new clients, improving logistics and ensuring our technical experts are close by. We are delighted to announce our plans to open a new Laboratory Facility in Massachusetts and a further announcement will be made soon.”
“On behalf of the Center, I would like to extend our warmest congratulations to the team at BioOutsource as they develop their U.S. lab facility here in Massachusetts,” said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center, the agency charged with implementing Governor Patrick’s 10-year, $1 billion Life Sciences Initiative.
“We are excited to welcome Gerry and his team to Massachusetts, as the gateway into business in the U.S.,” said Robert K. Coughlin, President & CEO of MassBio, the life sciences trade association. “BioOutsource has already been and will continue to be great ambassadors to companies across the world who want to work in and with our researchers.”
Source: Massachusetts Biotechnology Council